secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001140361-24-043244
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano lowers Q3 revenue guidance to $6.5-6.8M from $7.9-8.9M; cash $23.3M
---------------------------------------------------------------------------

- Preliminary Q3 revenue $6.5-6.8M, down from prior guidance of $7.9-8.9M.
- Cash and restricted cash ~$23.3M as of Sep 30; $11.4M restricted.
- Revenue miss driven by strategic shift away from new OGM system placements and sector headwinds.
- Potential material impairments and charges pending completion of end-of-period review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124043244/0001140361-24-043244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124043244/ef20037106_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-043244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer